Clinical Trials in Chicago

Showing 6241-6260 of 20,493 trials

Immune Ablation and Stem Cell Support for Crohn's Disease

NCT00179842

The investigators anticipate that this study will also form the basis to clarify further the role of the immune system in Crohn's disease.

Crohn Disease

Ann & Robert H Lurie Children's Hospital of ChicagoStarted Mar 2007

Chicago, Illinois, United States

TERMINATEDPhase 12.2 miles

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

NCT05241873

This is a Phase 1/2, open-label first-in-human study of the safety, pharmacokinetics (PK), pharmacodynamics, and anti-tumor activity of BLU-451 monotherapy and BLU-451 in combination with platinum-based chemotherapy (carboplatin and pemetrexed). All participants will receive BLU-451 on a 21-day treatment cycle.

Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more

Blueprint Medicines Corporation103 participantsStarted Mar 2022

Duarte, California, United States • Los Angeles, California, United States • Aurora, Colorado, United States +20 more locations

Immune Ablation and Stem Cell Support for Crohn's Disease

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Find Trials by Condition in Chicago

Rituximab + Immunotherapy in Follicular Lymphoma

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events

A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis

A Study of Imvotamab in Severe Systemic Lupus Erythematosus